Related Experiment Video
Updated: Apr 27, 2026
Merkel Cell Polyomavirus Infection and Detection
Published on: February 7, 2019
Primitive eyelid Merkel carcinoma.
1Head and Neck Department, Ophthalmology Multi-Speciality Department, Institute for Treatment and Research "Casa Sollievo Della Sofferenza", San Giovanni Rotondo, Foggia, Italy.
Primitive Merkel Cell Carcinoma (MCC) is a rare, aggressive eyelid cancer. Early, radical surgical removal with wide margins is crucial for improved survival rates and reduced recurrence risk.
Area of Science:
- Ophthalmology
- Dermatology
- Oncology
Background:
- Merkel Cell Carcinoma (MCC) is a rare, aggressive neuroendocrine skin cancer originating from Merkel cells.
- Eyelid MCC presents a unique clinical challenge due to the delicate anatomical structures involved.
Observation:
- A case study details a 65-year-old woman with a rapidly developing palpebral MCC over three months.
- Diagnosis may necessitate immuno-histochemical and ultrastructural analysis for confirmation.
Findings:
- Primitive Merkel Cell Carcinoma of the eyelid is a highly aggressive malignancy.
- Early and aggressive surgical resection with wide margins is the primary treatment strategy.
Implications:
- Prompt diagnosis and radical excision are vital to minimize distant recurrence and enhance patient survival.
- Adjuvant radiotherapy may be considered post-surgery to further reduce recurrence risk.
More Related Videos
06:15Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
08:13In Vivo Confocal Microscopy in the Diagnosis and Management of Dry Eye: A Focus on Imaging Protocols and Interpretation
Published on: November 11, 2025
